Search for dissertations about: "thrombotic microangiopathy"
Showing result 1 - 5 of 6 swedish dissertations containing the words thrombotic microangiopathy.
-
1. Studies of EHEC and the complement system in renal diseases
Abstract : This thesis addressed the diagnosis, pathogenesis and clinical course of specific renal diseases hemolytic uremic syndrome (HUS) and dense deposit disease (DDD). HUS may be associated with infection caused by Enterohemorrhagic Escherichia coli (EHEC) or with complement dysfunction due to complement mutations or auto-antibodies (atypical HUS, aHUS). READ MORE
-
2. Aspects of Complement Activation in Thrombocytopenic Disorders
Abstract : The complement system is an essential effector of both innate and acquired immune responses. Due to its destructive potential, tight regulation is required. The contribution of complement has been associated with the pathogeneses in a wide range of diseases. READ MORE
-
3. Studies of ADAMTS13 expression and activity in the kidney
Abstract : Von Willebrand factor (VWF) is an abundant plasma glycoprotein involved in platelet adhesion and aggregation at sites of vascular injury. ADAMTS13 is the sole physiological VWF-cleaving protease, thus regulating the size of thrombus growth. READ MORE
-
4. Clinical, epidemiological and molecular aspects of hemolytic uremic syndrome
Abstract : Hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure in children in the western world. HUS is characterized by the triad of hemolytic anemia, thrombocytopenia and renal failure. There are two main subtypes of HUS; typical or D+ (D stands for diarrhea) HUS associated with enterohemorrhagic E. READ MORE
-
5. Platelet activation and tissue factor release in hemolytic uremic syndrome
Abstract : Hemolytic uremic syndrome (HUS) is a clinical syndrome characterized by microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. There are two subtypes: typical HUS associated with enterohemorrhagic E. coli (EHEC) and atypical HUS associated with uninhibited activation of the alternative pathway of complement. READ MORE